🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Regeneron Perspectives: Research & Clinical Development Collaboration | Regeneron Corporate regeneron.com/perspectives/p…

I am very excited to share our study from ⁦Regeneron⁩, published today in ⁦⁦Nature Cancer⁩ . This very talented cross-functional team generated the first single-cell epigenetic map of immune cells in renal cell carcinoma. nature.com/articles/s4301…

A review visit at #BRSC “Fleming Institute” in Athens, turns into direct contact with history: Alexander Fleming’s original discoveries, his personal notebook/diary and artistic hand written notes. The birth of antibiotics and a huge step for mankind…#Science #antibiotics

We are looking for a Scientist (PhD level) Regeneron with expertise in CRISPR-based technologies to translate discoveries from multi-omics profiling of preclinical cancer models and patient samples into novel therapeutics. Spread the word! regeneron.wd1.myworkdayjobs.com/Careers/job/TA…

Thanks 🙏to ⁦Dr Louise Stone and Nature Reviews Urology⁩! for highlighting our recent RCC epigenomic profiling study published in Nature Cancer #regeneron “Mapping immune cell chromatin landscapes in ccRCC” | Nature Reviews Urology nature.com/articles/s4158…

The most powerful scientific engine is a diverse, collegial interdisciplinary lab that works together. Brainstorming and merging of ideas from people that think differently, is a powerful incubator for innovation. I am lucky to have such a lab!

Congratulations to the entire #regeneron team for publishing this beautiful work “A CD22xCD28 bispecific antibody enhances odronextamab activity in DLBCL” in lnkd.in/eKj46_Rf Keep pushing the boundaries of cancer immunotherapy to hopefully change the course of this disease

Our extensive report on #SITC22 is ready 👉acir.org/weekly-digests…. It includes talks from the following institutions and scientists: MD Anderson Cancer Center @MGH_RI Broad Institute Benjamin D. Greenbaum Memorial Sloan Kettering Cancer Center Vinod BalachandranMD MIT Biology dimitris skokos Michael Birnbaum @wusm_pathology 1/2

Thank you ACIR for highlighting our work.

Congratulation to Dylan Kwart and the entire team for publishing this beautiful work! A huge thank you to the Regeneron Post-doctoral program. cell.com/cell-reports/f…

Thank you ACIR for highlighting our work 🙏

Happy to share our review "CD28 co-stimulation: novel insights and applications in cancer immunotherapy" prepared together with Michael Lotze and Scott Olejniczak. nature.com/articles/s4157…

Thanks Nature Rev Immunol 🙏

Please join us for an exciting webinar/discussion on the "Clinical consideration of CD3 and CoStim. bispecific antibodies in solid tumors" organized by the Society for Immunotherapy of Cancer (SITC) higherlogicdownload.s3.amazonaws.com/SITCANCER/2c19…

Bring it on...

Indeed

#Vangelis #Rosetta #grammys2017 I hope tonight they will award the Grammy to the founder father of New Age music Vangelis!

youtu.be/Wtph-meLJ80 #vangelis#rosetta#garmmys2017